Finance

Lists
688506:SHA
Sichuan Biokin Pharmaceutical Co Ltd
CN¥233,88
+1,17%
(+2,71) 1D
16 Okt., 15:00:01 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 688506...
Open
CN¥233,33
High
CN¥242,99
Low
CN¥230,10
Mkt. cap
93,56 mjd
Avg. vol.
1,57 m
Volume
1,83 m
52-wk high
CN¥404,00
52-wk low
CN¥200,10
EPS
-CN¥3,79
No. of employees
3 k
Open
CN¥233,33
High
CN¥242,99
Low
CN¥230,10
Mkt. cap
93,56 mjd
Avg. vol.
1,57 m
Volume
1,83 m
52-wk high
CN¥404,00
52-wk low
CN¥200,10
EPS
-CN¥3,79
No. of employees
3 k
News stories
From web sources and news partners
Profile
Sichuan Biokin Pharmaceutical Co., Ltd. is a publicly listed Chinese biopharmaceutical company that is headquartered in Chengdu, Sichuan. Wikipedia
About Sichuan Biokin Pharmaceutical Co Ltd
CEO-
Employees3,43 k
Founded23 Aug. 1996
Headquarters-
SectorPharmaceutical industry
Websiteen.baili-pharm.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
1,89 mjd
454,22 m
94,59 m
92,75 m
Cost of goods sold
43,74 m
115,66 m
43,37 m
59,34 m
Cost of revenue
43,74 m
115,66 m
43,37 m
59,34 m
Research and development expenses
733,75 m
741,34 m
694,76 m
787,93 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
144,15 m
169,94 m
126,35 m
113,01 m
Operating expense
862,71 m
926,05 m
813,01 m
892,42 m
Total operating expenses
906,45 m
1,04 mjd
856,38 m
951,76 m
Operating income
988,25 m
-587,49 m
-761,79 m
-859,01 m
Other non operating income
-68,11 m
68,05 m
-142,74 m
142,75 m
EBT including unusual items
942,32 m
-535,84 m
-776,15 m
-901,42 m
EBT excluding unusual items
977,50 m
-586,93 m
-841,61 m
-965,12 m
Income tax expense
318,88 m
23,26 m
-1,59 m
-38,76 m
Effective tax rate
33,84%
-4,34%
0,21%
4,30%
Other operating expenses
-15,12 m
14,55 m
-7,43 m
-9,01 m
Net income
623,44 m
-559,10 m
-774,56 m
-862,66 m
Net profit margin
32,90%
-123,09%
-818,89%
-930,11%
Earnings per share
-
-
-
-
Interest and investment income
54,03 m
56,43 m
89,48 m
36,67 m
Interest expense
-24,43 m
-26,18 m
-26,56 m
-29,06 m
Net interest expenses
29,60 m
30,26 m
62,92 m
7,62 m
Depreciation and amortization charges
-
-
-
-
EBITDA
1,01 mjd
-567,21 m
-741,51 m
-836,43 m
Gain or loss from assets sale
1,06 k
-1,06 k
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme